[DreaMed in Business Wire] DreaMed Diabetes deploys diabetes data management and clinical decision support device into patients’ electronic medical records at Yale New Haven Health
NEW HAVEN, Conn. & TEL AVIV, Israel–(BUSINESS WIRE)–DreaMed Diabetes, a developer of AI-based diabetes care solutions, partnered with Yale New Haven Health System (YNHHS) Center for Health Care Innovation and successfully deployed DreaMed’s endo.digital clinical decision support system as a fully integrated component of Northeast Medical Group’s (NEMG) EMR workflow. Read...
Read More